Insights and Content Hub | Pharmaceutical Launch Excellence Summit US

Download your complimentary copy of the industry report today for an in-depth analysis of the trends, challenges and market forces shaping pharmaceutical launches. Explore the latest insights on market access, pricing and reimbursement, AI, launch execution, and evolving regulatory requirements, alongside real-world examples from leading pharmaceutical organisations.

• Why up to two-thirds of pharmaceutical launches fail to meet expectations and the common execution gaps separating launch readiness from launch success.
• How the first 6-12 months now determine long-term launch performance, with early access, adoption and payer decisions becoming increasingly difficult to reverse.
• The impact of the EU HTA Regulation and Joint Clinical Assessments, and what launch teams need to do now to prepare evidence strategies for a changing European market access landscape.
• How pricing, reimbursement and access pressures are reshaping launch strategy across Europe and the US, from Medicare negotiations to increasing payer scrutiny and value-based assessments.
• The rise of obesity, oncology and specialty therapies, with oncology spend forecast to exceed $440 billion globally by 2029 and obesity medicines projected to reach up to $280 billion by 2030.
• Practical AI use cases already improving launch performance, including forecasting, omnichannel optimisation, field enablement, medical insight generation and early signal detection.
• How leading organisations are evolving launch operating models, moving from milestone-based launch planning to continuous launch performance management.
• Real-world lessons from companies including AstraZeneca, Roche, Novartis, Teva and Sandoz on evidence generation, market access, launch sequencing and supply resilience
  

Launching a new therapy has never been more complex. The Launch Survival Checklist provides a practical framework for evaluating your team's readiness, identifying potential gaps and prioritzing the actions that matter most before and after launch. Covering the eight critical capabilities required for launch success, this resource includes readiness checklists, expert guidance and a launch resilience assessment to help teams build a stronger foundation for long-term market performance.

Get your copy today >>

AI in Pharmaceutical Launch Excellence: From Data to Decision-Making

AI is rapidly reshaping how pharmaceutical organisations approach launch planning, forecasting and execution. In this exclusive insight brief, discover how leading companies are using AI to turn complex data into actionable insights, improve commercial decision-making, strengthen market access strategies and drive stronger launch performance.

Download your complimentary copy today and explore the opportunities AI presents across the pharmaceutical launch lifecycle.

Connecting Challenges to Solutions: A Partnership Guide

This insight brief is designed specifically for those selling to and working with pharma launch teams, offering a concise overview of the key challenges facing pharmaceutical launch teams today and the opportunities they create for external partners.

By exploring where launch leaders are struggling, the guide highlights how consultants and technology/ service providers can position their solutions to address critical industry needs, create greater value for clients, and become strategic partners in launch success.

Get your complimentary copy today>